Marketing-authorisation holder
Biolab Sanus Farmaceutica Ltda
358 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
358 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 358
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABLOK | Atenolol | Brazil | Authorised | 2000 |
| ABLOK PLUS | Atenolol, Chlorthalidone | Brazil | Authorised | 1999 |
| ácido ursodesoxicólico | Ácido ursodesoxicólico | Brazil | Authorised | 2024 |
| ácido valpróico | Valproic acid | Brazil | Authorised | 2018 |
| AD-MUC | Matricaria recutita l. | Brazil | Authorised | 2003 |
| AGUD | Paracetamol, Codeine | Brazil | Authorised | 2018 |
| alfaestradiol | Alfaestradiol | Brazil | Authorised | 2020 |
| ALOZEX | Alfaestradiol | Brazil | Authorised | 2018 |
| apixabana | Apixaban | Brazil | Authorised | 2025 |
| ARADOIS | Losartan | Brazil | Authorised | 2001 |
| ARADOIS H | Losartan, Hydrochlorothiazide | Brazil | Authorised | 2001 |
| atenolol | Atenolol | Brazil | Authorised | 2018 |
| ATEROGREL | Clopidogrel | Brazil | Authorised | 2011 |
| ATIVB | Mecobalamin | Brazil | Authorised | 2022 |
| benfotiamina | Benfotiamina | Brazil | Authorised | 2023 |
| BESILATO DE ANLODIPINO | Anlodipino | Brazil | Authorised | 2021 |
| besilato de levanlodipino | Levanlodipino | Brazil | Authorised | 2015 |
| BHENA | Benazepril | Brazil | Authorised | 2020 |
| BILYT | Lithium | Brazil | Authorised | 2021 |
| BIOLME | Olmesartan medoxomilo | Brazil | Authorised | 2025 |
| BIOLME H | Olmesartan medoxomilo, Hydrochlorothiazide | Brazil | Authorised | 2025 |
| bissulfato de clopidogrel | Clopidogrel | Brazil | Authorised | 2021 |
| BIVOLET | Nebivolol | Brazil | Authorised | 2021 |
| bosentana | Bosentan | Brazil | Authorised | 2021 |
| bromidrato de citalopram | Citalopram | Brazil | Authorised | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 357 | 187 | 170 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.